Literature DB >> 16537084

Papillomavirus E2 protein interacts with and stimulates human topoisomerase I.

Randolph V Clower1, Yan Hu, Thomas Melendy.   

Abstract

The papillomavirus (PV) E2 protein plays a role in recruiting viral and cellular DNA replication factors, such as PV E1 or RPA to PV genomes. Using both purified proteins and through co-precipitation, it was determined that HPV-11 E2 binds human topoisomerase I. E2 can stimulate topoisomerase I DNA relaxation activity 3- to 4-fold. Conversely, topoisomerase I is unable to stimulate E2 DNA binding. These findings suggest that stimulation of topoisomerase I by E2 may help promote efficient relaxation of the torsional stress induced by PV DNA replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537084     DOI: 10.1016/j.virol.2006.02.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

2.  Acetylation of E2 by P300 Mediates Topoisomerase Entry at the Papillomavirus Replicon.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

3.  Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1.

Authors:  David Gagnon; Hélène Sénéchal; Claudia M D'Abramo; Jennifer Alvarez; Alison A McBride; Jacques Archambault
Journal:  Virology       Date:  2013-03-11       Impact factor: 3.616

Review 4.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

5.  Simian virus 40 DNA replication is dependent on an interaction between topoisomerase I and the C-terminal end of T antigen.

Authors:  Sujata Khopde; Daniel T Simmons
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

6.  Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.

Authors:  Mart Toots; Mart Ustav; Andres Männik; Karl Mumm; Kaido Tämm; Tarmo Tamm; Ene Ustav; Mart Ustav
Journal:  PLoS Pathog       Date:  2017-02-09       Impact factor: 6.823

7.  The molecular pathogenesis of Trichilemmal carcinoma.

Authors:  Jeong Hyun Ha; Cheol Lee; Kyu Sang Lee; Chang-Sik Pak; Choong-Hyun Sun; Youngil Koh; Hak Chang
Journal:  BMC Cancer       Date:  2020-06-03       Impact factor: 4.430

8.  The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network.

Authors:  Mandy Muller; Caroline Demeret
Journal:  Open Virol J       Date:  2012-12-28

9.  DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication.

Authors:  Molly L Bristol; Xu Wang; Nathan W Smith; Minkyeong P Son; Michael R Evans; Iain M Morgan
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

10.  The human papillomavirus DNA helicase E1 binds, stimulates, and confers processivity to cellular DNA polymerase epsilon.

Authors:  Michaelle Chojnacki; Thomas Melendy
Journal:  Nucleic Acids Res       Date:  2018-01-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.